Sirgel, F. A., Warren, R. M., Böttger, E. C., Klopper, M., Victor, T. C., & van Helden, P. D. (2015). Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks. PLoS One.
Styl cytowania ChicagoSirgel, Frederick A., Robin M. Warren, Erik C. Böttger, Marisa Klopper, Thomas C. Victor, i Paul D. van Helden. "Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks." PLoS One 2015.
Styl cytowania MLASirgel, Frederick A., et al. "Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks." PLoS One 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..